Literature DB >> 25160520

Long-term survival in bone-predominant metastatic urothelial carcinoma.

Jorge D Ramos1, Heather H Cheng1, Evan Y Yu2.   

Abstract

Entities:  

Keywords:  Bladder cancer; Bone metastases; Prognosis; Survival; Urothelial cancer

Mesh：

Year:  2014        PMID： 25160520      PMCID： PMC4252264          DOI： 10.1016/j.clgc.2014.07.005

Source DB:  PubMed          Journal:  Clin Genitourin Cancer        ISSN： 1558-7673            Impact factor:   2.872


× No keyword cloud information.
  21 in total

1.  Long-term survival in metastatic transitional-cell carcinoma and prognostic factors predicting outcome of therapy.

Authors:  D F Bajorin; P M Dodd; M Mazumdar; M Fazzari; J A McCaffrey; H I Scher; H Herr; G Higgins; M G Boyle
Journal:  J Clin Oncol       Date:  1999-10       Impact factor: 44.544

2.  Metastatic urothelial cancer: evaluation of prognostic factors and change in prognosis during the last twenty years.

Authors:  L Sengeløv; C Kamby; H von der Maase
Journal:  Eur Urol       Date:  2001-06       Impact factor: 20.096

3.  Long-term follow-up of a phase III intergroup study of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: a cooperative group study.

Authors:  S B Saxman; K J Propert; L H Einhorn; E D Crawford; I Tannock; D Raghavan; P J Loehrer; D Trump
Journal:  J Clin Oncol       Date:  1997-07       Impact factor: 44.544

4.  Metastatic pattern of bladder cancer: correlation with the characteristics of the primary tumor.

Authors:  Atul B Shinagare; Nikhil H Ramaiya; Jyothi P Jagannathan; Fiona M Fennessy; Mary-Ellen Taplin; Annick D Van den Abbeele
Journal:  AJR Am J Roentgenol       Date:  2011-01       Impact factor: 3.959

5.  Prognostic factors in patients with advanced transitional cell carcinoma of the urothelial tract experiencing treatment failure with platinum-containing regimens.

Authors:  Joaquim Bellmunt; Toni K Choueiri; Ronan Fougeray; Fabio A B Schutz; Yacine Salhi; Eric Winquist; Stéphane Culine; Hans von der Maase; David J Vaughn; Jonathan E Rosenberg
Journal:  J Clin Oncol       Date:  2010-03-15       Impact factor: 44.544

6.  Complete response of bony metastatic bladder urothelial cancer to neoadjuvant chemotherapy and cystectomy.

Authors:  Fadi N Joudi; Laila Dahmoush; David M Spector; Badrinath R Konety
Journal:  Urol Oncol       Date:  2006 Sep-Oct       Impact factor: 3.498

7.  A randomized comparison of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: a cooperative group study.

Authors:  P J Loehrer; L H Einhorn; P J Elson; E D Crawford; P Kuebler; I Tannock; D Raghavan; R Stuart-Harris; M F Sarosdy; B A Lowe
Journal:  J Clin Oncol       Date:  1992-07       Impact factor: 44.544

8.  Bladder cancer.

Authors:  Peter E Clark; Neeraj Agarwal; Matthew C Biagioli; Mario A Eisenberger; Richard E Greenberg; Harry W Herr; Brant A Inman; Deborah A Kuban; Timothy M Kuzel; Subodh M Lele; Jeff Michalski; Lance C Pagliaro; Sumanta K Pal; Anthony Patterson; Elizabeth R Plimack; Kamal S Pohar; Michael P Porter; Jerome P Richie; Wade J Sexton; William U Shipley; Eric J Small; Philippe E Spiess; Donald L Trump; Geoffrey Wile; Timothy G Wilson; Mary Dwyer; Maria Ho
Journal:  J Natl Compr Canc Netw       Date:  2013-04-01       Impact factor: 11.908

9.  T1G3 transitional cell carcinoma of the bladder: recurrence, progression and survival.

Authors:  M Peyromaure; M Zerbib
Journal:  BJU Int       Date:  2004-01       Impact factor: 5.588

10.  Comprehensive molecular characterization of urothelial bladder carcinoma.

Authors: 
Journal:  Nature       Date:  2014-01-29       Impact factor: 49.962
View more
  2 in total

1.  Role of Multimodal Treatment in Urothelial Carcinoma Spinal Metastasis: 15 Patients' Experiences in a Single Center.

Authors:  Tao Wang; Xin Gao; Kun Zhang; Jian Yang; Zheyu Wu; Tielong Liu; Qi Jia; Jianru Xiao
Journal:  Cancer Manag Res       Date:  2020-09-24       Impact factor: 3.989

2.  Bone Metastases as the Only Metastatic Site in Patients With Urothelial Carcinoma: Focus on a Special Patient Population.

Authors:  Andrea Necchi; Gregory R Pond; Sumanta K Pal; Neeraj Agarwal; Daniel W Bowles; Elizabeth R Plimack; Evan Y Yu; Sylvain Ladoire; Jack Baniel; Simon Crabb; Gunter Niegisch; Sandy Srinivas; Dominik R Berthold; Jonathan E Rosenberg; Thomas Powles; Aristotelis Bamias; Lauren C Harshman; Joaquim Bellmunt; Matthew D Galsky
Journal:  Clin Genitourin Cancer       Date:  2017-11-01       Impact factor: 2.872
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.